Search

everythinglearnresearchcommunity

for

Search:↓

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Conventional treatments like dutasteride and minoxidil are effective for male hair loss, with some alternative treatments also showing promise.

Experts recommend specific treatments like minoxidil and finasteride for managing hereditary hair loss.

New treatments for common hair loss include medications, regenerative therapies, and laser therapy, but may not work for everyone.

Effective hair loss treatment requires personalized approaches and patient-provider collaboration.

Combination therapy for hair loss can improve results and reduce side effects.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

New treatments for androgenetic alopecia show promise but need more research for validation.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Australia needs better dermatological guidelines for gender-diverse patients.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Androgens and estrogens are crucial for insulin secretion in males.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

CAM practitioners in the eThekwini area are exploring ways to manage and diagnose Polycystic Ovarian Syndrome.

Homoeopaths and traditional healers in KwaZulu-Natal have different understandings and ways of treating acne.

Lablab purpureus peptides may effectively kill cancer cells with fewer side effects.

Thuja orientalis and Thuja occidentalis essential oils have medicinal properties useful for developing treatments with antimicrobial and bioactive effects.